Autonomy tops £2 billion market cap as it forecasts another record quarter ahead

Autonomy Corporation plc (AU.L) said it expects to report record second quarter 2008 results, with revenues and earnings per share "significantly ahead" of consensus estimates.

The Cambridge-HQed global plyer in infrastructure software for the enterprise said revenues were expected to be between $122m and $125m, compared to analyst consensus revenue estimates of $118m.

It said adjusted earnings per share would be between 15.3 cents and 16.2 cents, while analyst consensus was for 12.9 cents.

CEO Mike Lynch said there was "strong trading" across "the broad spectrum of the application of our IDOL been achieved without recognizing revenues from recently announced large technology".

He said the results had banking deals.

The company said in a separate statement to the London Stock Exchange that it has signed a deal with Fox Entertainment Group for the license of Autonomy software.

News Corporation's Fox Entertainment Group owns film studios and terrestrial, cable, and direct broadcast satellite television properties.

Autonomy's share price was up 5p to 969.5p in early trading. The largest listed company headquartered in the Cambridge cluster of high tech companies is now valued at £2.08 billion.



Previous articles
Market warms to Meldex as it plans launch of treatments for insulin resistance, histamine intolerance
CAT, Intercytex lead the way in Biotech Revival
Briefs: New Chairman for Alizyme; CSR chip quals for v3.0 Bluetooth, new
Screen Technology reassures stock market and reverses share price fall
Market likes what it sees as Alyzyme enters pivotal period
Numbers don't matter in CMR Fuel Cells' maiden result: attention on product progress
BioProgress buys US-based airPharma for £4.2m; raises £6.15m in share placing
NXT ‘07 losses grow; plans to raise £2.35m, remains confident of future
Briefs: nCipher reports takeover approaches; AngioDynamics buys Diomed’s Cambridge business
Cambridge's SQW, Oxford Innovation merge: aim for IPO in 2 to 3 years
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • Abingworth Management


Stephen Bunting
Managing Director


Abingworth is a long-established venture capital firm specialising in investment in life science biomedical companies. With offices in London, Cambridge, Menlo Park and Boston, Abingworth is active on both sides of the Atlantic and has backed more than 90 developing life science/medical businesses.

[Abingworth Management's profile]


Top20 Index




Currently: 161